Glenmark Pharma

BSE: 532296 | NSE: GLENMARK
Glenmark Pharma (CIN: L24299MH1977PLC019982) operates in the Pharmaceuticals industry and has been listed in the stock market since 10 Feb 2000. It currents trades on NSE with symbol GLENMARK and on BSE with scrip code 532296.
The registered office of the company is B2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai, Maharashtra - 400026.

The management team of Glenmark Pharma is led by GLENN MARIO SALDANHA who is the Executive Director-Chairperson related to Promoter-CEO-MD. Other members of the management team consist of BLANCHE ELIZABETH SALDANHA (Designation:Non-Executive - Non Independent Director), CHERYLANN MARIA PINTO (Designation:Executive Director), SAIRA RAMASASTRY (Designation:Non-Executive - Independent Director), DIPANKAR BHATTACHARJEE (Designation:Non-Executive - Independent Director), VIJAYALAKSHMI RAJARAM IYER (Designation:Non-Executive - Independent Director), PRADEEP KUMAR SINHA (Designation:Non-Executive - Independent Director), ANURAG MANTRI (Designation:Executive Director), PATRICIA ANDREWS (Designation:Non-Executive - Independent Director), Rashmi Khandelwal (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Glenmark Pharma is as below -

BSE 2442 -30.1 (-1.22%)

BSE

2442 -30.1 (-1.22%)
Volume: 4,488.00
M. Cap: 68,434.91
P/E: 38.07
Prev. Close: 2,472.10
52 Wk

NSE 1643.5 -23.45 (-1.41%)

NSE

1643.5 -23.45 (-1.41%)
Volume: 4,38,364.00
M. Cap: 68,616.93
P/E: 38.07
Prev. Close: 2,475.00
52 Wk

Stock Price Chart

F&O Data

expiry_date open_price high_price low_price prev_close last_price volume turnover_lacs underlying_value
29-Sep-2026 2,456.00 2,469.90 2,420.40 2,480.40 2,421.00 10,530 96,415.44 2,430.40
27-Oct-2026 2,451.20 2,483.70 2,437.00 2,493.70 2,437.00 9,323 85,767.99 2,430.40
23-Nov-2026 2,488.30 2,488.30 2,454.00 2,505.00 2,459.00 16 147.86 2,430.40
Calls 29 Sep 2026 Puts
OI
(Delta OI)		 LTP
(Change)		 Intrinsic Value Time Value Strike Price Time Value Intrinsic Value LTP
(Change)		 OI
(Delta OI)
725
(-)		 -
 0 - 2,000 - 1476.35 -
 11,600
(-)
-
 -
 - - 2,040 - - -
 -
-
 -
 - - 2,060 - - -
 -
-
 -
 - - 2,080 -1555.05 1556.35 1.30
(+0.65)		 5,800
(-725)
2,900
(-)		 -
 0 - 2,100 -1575.5 1576.35 0.85
(+0.10)		 29,725
(-725)
-
 -
 - - 2,120 -1595.35 1596.35 1.00
(+0.20)		 13,775
(+725)
4,350
(-)		 -
 0 - 2,140 - 1616.35 -
 7,250
(-)
725
(-)		 -
 0 - 2,160 - 1636.35 -
 9,425
(-)
2,900
(-)		 -
 0 - 2,180 -1655.35 1656.35 1.00
(+0.15)		 11,600
(-)
73,225
(-)		 -
 0 - 2,200 -1675.25 1676.35 1.10
(+0.20)		 52,200
(-3,625)
3,625
(-)		 -
 0 - 2,220 -1695.1 1696.35 1.25
(-1.10)		 14,500
(-)
12,325
(-)		 -
 0 - 2,240 -1714.9 1716.35 1.45
(+0.10)		 25,375
(-4,350)
20,300
(-)		 -
 0 - 2,260 -1734.45 1736.35 1.90
(-1.40)		 52,200
(-725)
28,275
(-)		 -
 0 - 2,280 - 1756.35 -
 36,250
(-)
1,88,500
(-725)		 130.00
(-47.30)		 0 130 2,300 -1773.95 1776.35 2.40
(+0.70)		 1,66,750
(-42,775)
26,825
(-)		 -
 0 - 2,320 -1793.05 1796.35 3.30
(+1.50)		 51,475
(-10,875)
49,300
(-)		 94.05
(-46.75)		 0 94 2,340 -1812.15 1816.35 4.20
(+2.25)		 32,625
(-17,400)
58,000
(-)		 -
 0 - 2,360 -1829.95 1836.35 6.40
(+3.85)		 1,11,650
(+5,075)
42,775
(-725)		 80.10
(+0.15)		 0 80 2,380 -1846.05 1856.35 10.30
(+6.80)		 71,775
(-1,450)
6,69,900
(-13,775)		 41.90
(-42.05)		 0 42 2,400 -1860.55 1876.35 15.80
(+11.00)		 3,71,925
(+68,150)
1,02,950
(+7,250)		 27.85
(-38.00)		 0 28 2,420 -1872.1 1896.35 24.25
(+16.55)		 92,075
(+7,975)
1,69,650
(+53,650)		 19.25
(-30.40)		 0 19 2,440 -1880.95 1916.35 35.40
(+23.50)		 1,03,675
(-38,425)
2,10,250
(+59,450)		 12.15
(-25.00)		 0 12 2,460 -1888.45 1936.35 47.90
(+29.40)		 1,07,300
(-5,800)
2,11,700
(-21,025)		 8.35
(-18.25)		 0 8 2,480 -1891.95 1956.35 64.40
(+36.35)		 60,900
(+2,900)
9,57,725
(+25,375)		 5.90
(-12.35)		 0 6 2,500 -1894.2 1976.35 82.15
(+42.60)		 64,525
(-6,525)
1,42,100
(-23,925)		 3.70
(-8.25)		 0 4 2,520 - 1996.35 -
 40,600
(-)
3,31,325
(-7,975)		 2.45
(-5.65)		 0 2 2,540 - 2016.35 -
 13,775
(-)
1,79,075
(-39,875)		 2.10
(-3.65)		 0 2 2,560 - 2036.35 -
 2,175
(-)
23,200
(-10,150)		 1.50
(-2.60)		 0 2 2,580 - - -
 -
3,88,600
(-34,075)		 1.25
(-2.00)		 0 1 2,600 -1901.35 2076.35 175.00
(+50.95)		 18,125
(-725)
8,700
(+2,900)		 1.55
(-0.90)		 0 2 2,620 - - -
 -
66,700
(-8,700)		 0.90
(-1.00)		 0 1 2,640 - 2116.35 -
 51,475
(-)
2,900
(-)		 -
 0 - 2,660 - 2136.35 -
 3,625
(-)
31,175
(-12,325)		 0.70
(-0.65)		 0 1 2,680 - 2156.35 -
 4,350
(-)
31,900
(-)		 0.90
(-0.45)		 0 1 2,700 - 2176.35 -
 3,625
(-)
1,00,050
(-39,875)		 1.05
(-0.55)		 0 1 2,720 - 2196.35 -
 5,075
(-)
12,325
(-)		 0.75
(-0.65)		 0 1 2,740 - 2216.35 -
 2,900
(-)
2,175
(-)		 -
 0 - 2,760 - 2236.35 -
 2,175
(-)
32,625
(-20,300)		 0.70
(-)		 0 1 2,800 - 2276.35 -
 2,175
(-)
14,500
(-)		 -
 0 - 2,840 - - -
 -

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 13,16,52,682 46.65
Pledge 0 0.00
Foreign Institutions 5,74,13,527 20.35
Financial Institutions 5,42,35,607 19.22
NBFC and Mutual Funds 4,74,04,903 16.80
Others 3,88,98,993 13.78
Total 32,96,05,712 116.8

Financial Data

Consolidated
Figures in crore 2026 2025 2024
Net Sales 16,982.51 13,321.74 11,813.10
Operating Profit 2,766.96 2,092.28 1,531.70
Other Income 460.62 113.72 1,237.32
Interest 208.73 207.07 515.97
Depreciation 573.48 486.01 581.91
Profit Before Tax 1,984.75 1,399.20 433.82
Tax 622.80 352.06 1,867.34
Profit After Tax 1,361.95 1,047.14 -1,433.52
Share Capital 28.22 28.22 28.22
Reserves 10,483.89 8,821.22 7,819.71
Net Worth 10,512.11 8,849.44 7,847.93
Loans 3,125.65 2,948.63 1,771.45
Gross Block 12,071.85 10,364.92 9,619.64
Investments 42.36 56.36 789.66
Cash 1,176.26 1,705.23 1,659.46
Debtors 4,963.35 3,341.95 1,858.41
Net Working Capital 6,771.41 6,419.70 3,957.28
Operating Profit Margin (%) 16.29 15.71 12.97
Net Profit Margin (%) 8.02 7.86 -12.14
EPS 48.26 37.11 -53.21
Dividend (%) 500.00 250.00 250.00
Dividend Payout 141.10 70.55 70.54
Standalone
Figures in crore 2026 2025 2024
Net Sales 8,440.10 9,226.41 7,891.12
Operating Profit 48.57 2,421.38 7,480.02
Other Income 772.02 356.37 6,238.36
Interest 78.75 48.73 277.11
Depreciation 235.89 218.63 202.16
Profit Before Tax -,266.07 2,154.02 7,000.75
Tax -65.27 543.67 1,833.46
Profit After Tax -,200.80 1,610.35 5,167.29
Share Capital 28.22 28.22 28.22
Reserves 24,122.10 24,475.74 22,942.40
Net Worth 24,150.32 24,503.96 22,970.62
Loans 1,698.10 961.89 839.23
Gross Block 4,015.83 3,743.15 3,392.75
Investments 15,202.21 15,194.91 12,964.79
Cash 293.19 132.74 129.15
Debtors 3,305.59 2,550.16 2,484.47
Net Working Capital 8,458.99 8,137.20 8,891.16
Operating Profit Margin (%) 0.58 26.24 94.79
Net Profit Margin (%) -2.38 17.45 65.48
Earning Per Share (Rs) -7.12 57.07 183.11
Dividend (%) 500.00 250.00 250.00
Dividend Payout 141.10 70.55 70.54
Dividend Declared (₹)
The company has declared dividend 5 times between 18 Sep 2023 and 31 Aug 2026, totaling Rs. 10.00 so far. The most recent dividend was declared on 31 Aug 2026 for Rs. 2.5.

Financial Data Graph

The peers of Glenmark Pharma are LUPIN, ALKEM and IPCALAB. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.